Showing posts with label CTA. Show all posts
Showing posts with label CTA. Show all posts

Monday, June 1, 2020

CT Angiography in Patients with Minor Strokes

A paper published in Radiology reports that CT angiography in patients with acute minor strokes was found to be beneficial in patients who are candidates for thrombectomy

The searchers stated that while minor strokes represent up to two-thirds of all cases of acute ischemic strokes, it's unknown whether CT angiography (CTA) to evaluate large-vessel occlusion in patients with minor stroke is cost-effective.

Large vessel occlusion is present in around 18% of patients with National Institutes of Health Stroke Scale (NIHSS) scores of 0-4 and 39% of patients with NIHSS scores of 5-8, but the authors said CTA is only recommended as a cost effective study to triage patients with acute minor stroke and find potential candidates for mechanical thrombectomy.  

The authors concluded that screening for large vessel occlusion with CTA in patients with acute minor stroke is cost effective and is associated with better outcome .




Tuesday, April 14, 2015

Anatomical versus Functional Testing for Coronary Artery Disease

Douglas et al in their article in NEJM compared the outcomes of anatomical versus functional tests in patients with coronary artery disease. 

They randomly assigned 10,003 symptomatic patients to an initial anatomical testing with the use of coronary computed tomographic angiography (CTA) or to functional testing (exercise electrocardiography, nuclear stress testing, or stress echocardiography). The composite primary end point was death, myocardial infarction, hospitalization for unstable angina, or major procedural complication. Secondary end points included invasive cardiac catheterization that did not show obstructive CAD and radiation exposure.

The mean age of the patients was 60.8±8.3 years, 52.7% were women, and 87.7% had chest pain or dyspnea on exertion. The mean pretest likelihood of obstructive CAD was 53.3±21.4%. Over a median follow-up period of 25 months, a primary end-point event occurred in 164 of 4996 patients in the CTA group (3.3%) and in 151 of 5007 (3.0%) in the functional-testing group. CTA was associated with fewer catheterizations showing no obstructive CAD than was functional testing (3.4% vs. 4.3%, P=0.02), although more patients in the CTA group underwent catheterization within 90 days after randomization (12.2% vs. 8.1%). The median cumulative radiation exposure per patient was lower in the CTA group than in the functional-testing group (10.0 mSv vs. 11.3 mSv), but 32.6% of the patients in the functional-testing group had no exposure, so the overall exposure was higher in the CTA group (mean, 12.0 mSv vs. 10.1 mSv; P<0.001).

In symptomatic patients with suspected CAD who required noninvasive testing, a strategy of initial CTA, as compared with functional testing, did not improve clinical outcomes over a median follow-up of 2 years suggesting that patients with chest pain have no less risk of heart attack, dying or being hospitalized than those who take a simple stress test.